Medical Plants Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran
Biosci Rep. 2019 Jan 11;39(1). doi: 10.1042/BSR20181538. Print 2019 Jan 31.
Some medicinal herbs and compounds are known to target cancer cells, but the success of them as anticancer compounds depends to a large extent on their ability to activate pathways that kill cancer cells by arresting cell cycle and inducing apoptosis. The aim of the present study was to determine the anticancer effects of on the breast cancer cells to reveal the underlying mechanism of its anti-breast cancer properties. In this experimental study, triple negative breast cancer cell line (MDA-MB-231) was cultivated in RPMI-1640 medium. Hydroalcoholic extract (70:30) of aerial parts of the plant was prepared. The cultured cells were treated with different concentrations (0-1000 μg/ml) of extract for 24 and 48 h. Toxicity of the extract on MDA-MB-231 cells was examined using MTT (3-[4,5-dimethyl-2-thiazolyl]-2, 5 diphenyl tetrazolium bromide) test. The Annexin V-FITC Apoptosis Detection Kit was used to evaluate apoptosis and necrosis. Flow cytometry technique was employed to differentiate different phases of the cell cycle in the cells. Data were analyzed by GraphPad Prism and SPSS software. After 24 and 48 h, the IC50 values were respectively 76.78 (95% CI = 60.75-97.05; = 0.8588) and 59.71 (95% CI = 46.25-77.09; = 0.8543) μg/ml for The extract exhibited antiproliferative effects against MDA-MB-231 cells in a dose-dependent manner. Annexin V-FITC/PI assay confirmed that the extract was able to induce apoptosis in MDA-MB-231 cells. Moreover, treatment with the extract resulted in cell cycle arrest at G1 phase. Therefore, could induce apoptosis and cycle arrest in the MDA-MB-231 cell line. It might be a good resource of natural products for producing anti-breast cancer drugs.
一些草药和化合物被发现可以靶向癌细胞,但它们作为抗癌化合物的成功在很大程度上取决于它们激活途径的能力,这些途径通过阻止细胞周期和诱导细胞凋亡来杀死癌细胞。本研究的目的是确定 对乳腺癌细胞的抗癌作用,以揭示其抗乳腺癌特性的潜在机制。在这项实验研究中,培养三阴性乳腺癌细胞系(MDA-MB-231)在 RPMI-1640 培养基中。制备植物地上部分的水醇提取物(70:30)。将培养的细胞用不同浓度(0-1000μg/ml)的 提取物处理 24 和 48 小时。用 MTT(3-[4,5-二甲基-2-噻唑基]-2,5-二苯基四氮唑溴化物)试验检测提取物对 MDA-MB-231 细胞的毒性。使用 Annexin V-FITC 凋亡检测试剂盒评估凋亡和坏死。采用流式细胞术技术区分细胞周期的不同阶段。数据由 GraphPad Prism 和 SPSS 软件分析。在 24 和 48 小时后,IC50 值分别为 76.78(95%CI=60.75-97.05; = 0.8588)和 59.71(95%CI=46.25-77.09; = 0.8543)μg/ml。该提取物以剂量依赖的方式对 MDA-MB-231 细胞表现出增殖抑制作用。Annexin V-FITC/PI 检测证实该提取物能够诱导 MDA-MB-231 细胞凋亡。此外,用提取物处理导致细胞周期停滞在 G1 期。因此, 能够诱导 MDA-MB-231 细胞系凋亡和细胞周期停滞。它可能是产生抗乳腺癌药物的天然产物的良好资源。